Sepsis-Associated Mortality, Resource Use, and Healthcare Costs: A Propensity-Matched Cohort Study
- PMID: 33372748
- DOI: 10.1097/CCM.0000000000004777
Sepsis-Associated Mortality, Resource Use, and Healthcare Costs: A Propensity-Matched Cohort Study
Abstract
Objectives: To examine long-term mortality, resource utilization, and healthcare costs in sepsis patients compared to hospitalized nonsepsis controls.
Design: Propensity-matched population-based cohort study using administrative data.
Setting: Ontario, Canada.
Patients: We identified a cohort of adults (≥ 18) admitted to hospitals in Ontario between April 1, 2012, and March 31, 2016, with follow-up to March 31, 2017. Sepsis patients were flagged using a validated International Classification of Diseases, 10th Revision-coded algorithm (Sepsis-2 definition), including cases with organ dysfunction (severe sepsis) and without (nonsevere). Remaining hospitalized patients were potential controls. Cases and controls were matched 1:1 on propensity score, age, sex, admission type, and admission date.
Interventions: None.
Measurements and main results: Differences in mortality, rehospitalization, hospital length of stay, and healthcare costs were estimated, adjusting for remaining confounders using Cox regression and generalized estimating equations. Of 270,669 sepsis cases, 196,922 (73%) were successfully matched: 64,204 had severe and 132,718 nonsevere sepsis (infection without organ dysfunction). Over follow-up (median 2.0 yr), severe sepsis patients had higher mortality rates than controls (hazard ratio, 1.66; 95% CI, 1.63-1.68). Both severe and nonsevere sepsis patients had higher rehospitalization rates than controls (hazard ratio, 1.53; 95% CI, 1.50-1.55 and hazard ratio, 1.41; 95% CI, 1.40-1.43, respectively). Incremental costs (Canadian dollar 2018) in sepsis cases versus controls at 1-year were: $29,238 (95% CI, $28,568-$29,913) for severe and $9,475 (95% CI, $9,150-$9,727) for nonsevere sepsis.
Conclusions: Severe sepsis was associated with substantially higher long-term risk of death, rehospitalization, and healthcare costs, highlighting the need for effective postdischarge care for sepsis survivors.
Copyright © 2020 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Conflict of interest statement
Ms. Farrah's and Dr. Thavorn's institution received funding from The Ottawa Hospital Academic Medical Organization. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
Late Mortality From Sepsis: What We Know and What It Means.Crit Care Med. 2021 Feb 1;49(2):353-355. doi: 10.1097/CCM.0000000000004795. Crit Care Med. 2021. PMID: 33438972 No abstract available.
References
-
- Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013. 2016Rockville, MD: HCUP Statistical Brief #204. Agency for Healthcare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hosp... . Accessed May 21, 2020
-
- Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017; 377:414–417
-
- Prescott HC, Iwashyna TJ, Blackwood B, et al. Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med. 2019; 200:972–981
-
- Goodwin AJ, Ford DW. Readmissions among sepsis survivors: Risk factors and prevention. Clin Pulm Med. 2018; 25:79–83
-
- Huang CY, Daniels R, Lembo A, et al.; Sepsis Survivors Engagement Project (SSEP). Life after sepsis: An international survey of survivors to understand the post-sepsis syndrome. Int J Qual Health Care. 2019; 31:191–198
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
